Etranacogene Dezaparvovec for Hemophilia B: Efficacy and Safety Four Years Post-Infusion
Clinician's RoundtableEtranacogene Dezaparvovec for Hemophilia B: Efficacy and Safety Four Years Post-Infusion
Investigating Gene Therapy for DMD: The Role of Caregiver-Reporter Scales
NeuroFrontiersInvestigating Gene Therapy for DMD: The Role of Caregiver-Reporter Scales
Next Steps in Gene Therapy Research for Duchenne Muscular Dystrophy
NeuroFrontiersNext Steps in Gene Therapy Research for Duchenne Muscular Dystrophy
Diagnosing NTM and Bronchiectasis: Best Practices for Early and Accurate Recognition
Deep Breaths: Updates from CHESTDiagnosing NTM and Bronchiectasis: Best Practices for Early and Accurate Recognition
Complexities in ATTR-CM Care: Key Considerations for Accurate Diagnosis
Heart MattersComplexities in ATTR-CM Care: Key Considerations for Accurate Diagnosis
Advances in Care for ATTR-CM: Current and Emerging Strategies
Heart MattersAdvances in Care for ATTR-CM: Current and Emerging Strategies
Recent Guidelines Updates: Implications to Practice
MinuteCE®Recent Guidelines Updates: Implications to Practice
Advancing Cystic Fibrosis: Addressing Disparities, Challenging Perceptions, and Innovating Patient-Centered Care
CME/CEAdvancing Cystic Fibrosis: Addressing Disparities, Challenging Perceptions, and Innovating Patient-Centered Care
Mastering the Complexity of AML Treatment: A Multidimensional Approach to Diagnosis, Therapy, and Side Effect Management
CME/CEMastering the Complexity of AML Treatment: A Multidimensional Approach to Diagnosis, Therapy, and Side Effect Management
APPlexus Hot Topics 2024: Clinical Updates on Non-Covalent BTK Inhibitors in CLL and MCL
CME/CEAPPlexus Hot Topics 2024: Clinical Updates on Non-Covalent BTK Inhibitors in CLL and MCL
Decoding Gene Therapy for Hemophilia B: Expert Insights on Common Myths
Medical Industry FeatureDecoding Gene Therapy for Hemophilia B: Expert Insights on Common Myths
Evaluating First-Line Therapy for Acute
Graft-Versus-Host DiseaseMedical Industry FeatureEvaluating First-Line Therapy for Acute
Graft-Versus-Host DiseaseUpgrade Your Adult Patients’ IgAN Treatment
Medical Industry FeatureUpgrade Your Adult Patients’ IgAN Treatment
CV Risk in Patients with Narcolepsy: See the Data
Medical Industry FeatureCV Risk in Patients with Narcolepsy: See the Data
IgAN Insights: The Potential Role of the Complement System in Disease Progression
Medical Industry FeatureIgAN Insights: The Potential Role of the Complement System in Disease Progression
Identifying Patients at High-Risk for IgAN Progression: Key Factors to Know
Medical Industry FeatureIdentifying Patients at High-Risk for IgAN Progression: Key Factors to Know